Skip to main content
SpringerLink
Log in

Cholecystokinin as a potent diagnostic marker for gastric cancer

  • Original Article
  • Published:
BioChip Journal Aims and scope Submit manuscript

Abstract

There is no early diagnosis marker for gastric cancer even though the gastric cancer is the second cause of deaths in East Asia. The aim of the current research is to develop a new diagnostic marker of gastric cancer. Commercially available ELISA kits were used to evaluate the peptide levels in plasma collected from Korean healthy and gastric cancer patients. About 1.5 fold decreased plasma cholecystokinin levels were measured in gastric cancer patients (n=75) than in healthy controls (n=36). Plasma cholecystokinin has no age, sex, and disease-dependent variation in control and patients sample. Receiver-operating characteristic curve analysis assessing the performance of cholecystokinin levels as the sensitivity of 94.7% and specificity of 100 % compared to healthy controls. These findings suggest plasma cholecystokinin as a useful biomarker for diagnosis of gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hartgrink, H.H., Jansen, E.P.M., van Grieken, N.C.T. & van de Velde, C.J.H. Gastric cancer. Lancet 374, 477–490 (2009).

    Article  Google Scholar 

  2. Jung, K.W. Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008. Cancer Res. Treat. 43, 1–11 (2011).

    Article  Google Scholar 

  3. Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893–2917 (2010).

    Article  CAS  Google Scholar 

  4. Ushijima, T. & Sasako, M. Focus on gastric cancer. Cancer Cell 5, 121–125 (2004).

    Article  CAS  Google Scholar 

  5. Mirvish, S.S. Gastric cancer and salivary nitrate and nitrite. Nature 315, 461–462 (1985).

    Article  CAS  Google Scholar 

  6. Shin, C.M. et al. Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis. Cancer Sci. 101, 1337–1346 (2010).

    Article  CAS  Google Scholar 

  7. Inoue, H., Kudo, S. & Shiokawa, A. Technology insight: Laser-scanning confocal microscopy and endocytoscopy for cellular observation of the gastrointestinal tract. Nat. Clin. Pract. Gastr. 2, 31–37 (2005).

    Article  Google Scholar 

  8. Lam, K.W.K. & Lo, S.C.L. Discovery of diagnostic serum biomarkers of gastric cancer using proteomics. Proteom. Clin. Appl. 2, 219–228 (2008).

    Article  CAS  Google Scholar 

  9. Cao, M. et al. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens. 78, 120–128 (2011).

    Article  CAS  Google Scholar 

  10. Kikuchi, R. et al. Low Serum Levels of Pepsinogen and Gastrin 17 Are Predictive of Extensive Gastric Atrophy with High-Risk of Early Gastric Cancer. Tohoku J. Exp. Med. 223, 35–44 (2011).

    Article  CAS  Google Scholar 

  11. Lin, L.L., Huang, H.C. & Juan, H.F. Discovery of biomarkers for gastric cancer: A proteomics approach. J. Proteomics. 75, 3081–3097 (2012).

    Article  CAS  Google Scholar 

  12. Compare, D. et al. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis. J. Clin. Pathol. 64, 677–682 (2011).

    Article  Google Scholar 

  13. Rehfeld, J.F., Friis-Hansen, L., Goetze, J.P. & Hansen, T.V. The biology of cholecystokinin and gastrin peptides. Curr. Top. Med. Chem. 7, 1154–1165 (2007).

    Article  CAS  Google Scholar 

  14. Yasui, W., Sumiyoshi, H., Ochiai, A. & Tahara, E. Cholecystokinin inhibition of tumor growth and gastrin-stimulated cyclic adenosine 3’: 5’-monophosphate metabolism in human gastric carcinoma in nude mice. Cancer Res. 46, 740–743 (1986).

    CAS  Google Scholar 

  15. Bradwejn, J., Koszycki, D. & Shriqui, C. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch. Gen. Psychiatry 48, 603–610 (1991).

    Article  CAS  Google Scholar 

  16. Paloheimo, L.I., Clemmesen, O., Dalhoff, K. & Rehfeld, J.F. Plasma cholecystokinin and its precursors in hepatic cirrhosis. J. Hepatol. 27, 299–305 (1997).

    Article  CAS  Google Scholar 

  17. Reubi, J.C. et al. Procholecystokinin as marker of human Ewing sarcomas. Clin. Cancer Res. 10, 5523–5530 (2004).

    Article  CAS  Google Scholar 

  18. Mathias, C.J. et al. Cardiovascular, Biochemical and Hormonal Changes during Food-Induced Hypotension in Chronic Autonomic Failure. J. Neurol. Sci. 94, 255–269 (1989).

    Article  CAS  Google Scholar 

  19. Laverman, P. et al. Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin. Eur. J. Nucl. Med. Mol. Imaging 35, 386–392 (2008).

    Article  CAS  Google Scholar 

  20. Wank, S.A., Pisegna, J.R. & Deweerth, A. Brain and Gastrointestinal Cholecystokinin Receptor Family -Structure and Functional Expression. P. Natl. Acad. Sci. USA 89, 8691–8695 (1992).

    Article  CAS  Google Scholar 

  21. Evers, B.M. Neurotensin and growth of normal and neoplastic tissues. Peptides 27, 2424–2433 (2006).

    Article  Google Scholar 

  22. Carraway, R.E. & Plona, A.M. Involvement of neurotensin in cancer growth: Evidence, mechanisms and development of diagnostic tools. Peptides 27, 2445–2460 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Recognition Research Center, Korea Institute of Science and Technology, Seoul, 02792, Korea

    Hafeza Akter, Young Sook Yoo & Min-Jung Kang

  2. Department of Biological Chemistry, Korea University of Science and Technology, Daejeon, 34113, Korea

    Hafeza Akter & Min-Jung Kang

  3. Department of General Surgery, The Catholic University of Korea, Seoul, 06591, Korea

    Won Sang Park

Authors
  1. Hafeza Akter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Young Sook Yoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Won Sang Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Min-Jung Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Min-Jung Kang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akter, H., Yoo, Y.S., Park, W.S. et al. Cholecystokinin as a potent diagnostic marker for gastric cancer. BioChip J 11, 14–20 (2017). https://doi.org/10.1007/s13206-016-1103-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13206-016-1103-x

Keywords

Search

Navigation